首页> 外文OA文献 >The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia

【2h】

The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia

机译：ApioID糖肽MMP-2200和NMDA受体拮抗剂的组合通过其自身减少了L-DOPA诱导的L-DOPA诱导的止吐剂和MMP-2200，还原多巴胺受体2样的激动剂诱导的嗜久血症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Andrew J. Flores; Mitchell J. Bartlett; Brandon K. Root; Kate L. Parent; Michael L. Heien; Frank Porreca; Robin Polt; Scott J. Sherman; Torsten Falk;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia [J] . Flores Andrew J., Bartlett Mitchell J., Root Brandon K., Neuropharmacology . 2018,第期

机译：ApioID糖肽MMP-2200和NMDA受体拮抗剂的组合通过其自身减少了L-DOPA诱导的诱导的达腹剂和MMP-2200，其含量减少了多巴胺受体2样激动剂诱导的嗜久血症
2. Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias [J] . GardoniF., SgobioC., PendolinoV., Neurobiology of Aging: Experimental and Clinical Research . 2012,第9期

机译：靶向含有NR2A的NMDA受体可减少L-DOPA引起的运动障碍
3. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates L-DOPA-induced dyskinesia in dopamine-denervated mice [J] . Mango Dalila, Bonito-Oliva Alessandra, Ledonne Ada, Experimental Neurology . 2014,第Null期

机译：腺苷A1受体刺激可降低来自斯特拉多 - 末端末端的D1受体介导的胃肠杆菌传递，并衰减在多巴胺去除的小鼠中的L-DOPA诱导的止吐剂
4. Pharmacological approaches to reduce and prevent L-Dopa-induced dyskinesias in a simian model of Parkinson's disease. [D] . Samadi, Pershia. 2005

机译：在帕金森病的猿猴模型中减少和预防L-多巴引起的运动障碍的药理方法。
5. The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesiaand MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia [O] . Andrew J. Flores, Mitchell J. Bartlett, Brandon K. Root, -1

机译：阿片类糖肽MMP-2200和NMDA受体拮抗剂的组合可减轻L-DOPA引起的运动障碍和MMP-2200本身可减轻多巴胺受体2样激动剂引起的运动障碍
6. The selective κ-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates [O] . H COX, D TOGASAKI, L CHEN, 2007

机译：选择性κ-阿片受体激动剂U50,488减少了L-DOPA诱导的止吐剂，但在MPTP治疗的灵长类动物中恶化了Parkinsonism

The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia

著录项

相似文献

相关主题

期刊订阅